MHRA Approves Dovonex Psoriasis Ointment

 The UK Medicines and Healthcare products Regulatory Agency has approved Dovonex for psoriasis treatment.

The ointment will be available to adults over 18 without a prescription after a consultation with a pharmacist to diagnosed psoriasis patients. The product can be used up to 12 weeks, after which patients are advised to consult a doctor.

The ointment, containing vitamin D analog calcipotriol, will be provided in 60g tubes.